iShares Trust - iShares Biotechnology ETF NasdaqGM:IBB Stock Report

Last Price

US$138.66

Market Cap

US$6.6b

7D

1.0%

1Y

3.0%

Updated

02 Feb, 2025

Data

Company Financials

iShares Trust - iShares Biotechnology ETF

NasdaqGM:IBB Stock Report

Market Cap: US$6.6b

IBB Stock Overview

An exchange traded fund launched by BlackRock, Inc. More details

IBB fundamental analysis
Snowflake Score
Valuation	1/6
Future Growth	0/6
Past Performance	1/6
Financial Health	4/6
Dividends	0/6

My Notes

Capture your thoughts, links and company narrative

iShares Trust - iShares Biotechnology ETF Competitors

Price History & Performance

Summary of share price highs, lows and changes for iShares Trust - iShares Biotechnology ETF
Historical stock prices
Current Share Price	US$138.66
52 Week High	US$150.57
52 Week Low	US$123.60
Beta	0.73
1 Month Change	3.36%
3 Month Change	-2.93%
1 Year Change	3.02%
3 Year Change	6.15%
5 Year Change	14.10%
Change since IPO	311.66%

Recent News & Updates

iShares Biotechnology ETF: Playing Defense

Dec 10

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28

Recent updates

iShares Biotechnology ETF: Playing Defense

Dec 10

IBB: A Near-20x P/E Is Historically Pricey, Technical Trends Neutral

Oct 14

iShares Biotechnology ETF: Significant Upside Potential As Sector Gains Momentum

Jul 28

Biotech Stocks 2024 Second Half Outlook - Buy Biotechs

Jul 09

IBB: Let It Rest

Mar 26

IBB ETF: On Sale And Rich Option Premium To Boot

Sep 20

IBB: Biotechnology Offers A Compelling Opportunity As It Builds Up Momentum

Jul 19

IBB: M&As Are Back

Jun 21

XBI Or IBB: How To Play The Oversold Biotech Most Efficiently

Jun 09

IBB: Lows After Highs Highlight Failing Growth Narratives And Overvaluation In Biotech Sector

May 09

IBB: Healthcare Dashboard For April

Apr 18

XBI And IBB: You May Keep Laughing While We Keep Buying This March 2020-Like Opportunity

Jan 28

Biotech Investing: Large Trading Volumes Suggest Better Days Are Ahead

Jan 17

IBB And XBI: 4 Reasons To Buy Biotech Stocks Ahead Of 2022

Dec 06

IBB: Healthcare Dashboard For October

Oct 15

IBB: Risks And Hedging

Sep 21

IBB: Growth And Innovation

Jun 28

AbbVie rated buy at Mizuho despite patent cliff for Humira

Jan 11

NASDAQ Biotech Index cross 5,000-mark as vaccine makers and gene-editors surge

Jan 08

iShares Nasdaq Biotechnology ETF: Continuous Innovation For Mankind

Jan 06

Citing uncertainty, Baird stays neutral on Biotech for 2021

Jan 04

COVID-19 vaccine makers: Looking back on 2020 seeking insights for 2021

Dec 31

Shareholder Returns

	IBB	US Capital Markets	US Market
7D	1.0%	0.3%	-0.9%
1Y	3.0%	44.4%	22.6%

Return vs Industry: IBB underperformed the US Capital Markets industry which returned 44.4% over the past year.

Return vs Market: IBB underperformed the US Market which returned 22.6% over the past year.

Price Volatility

Is IBB's price volatile compared to industry and market?
IBB volatility
IBB Average Weekly Movement	2.9%
Capital Markets Industry Average Movement	4.2%
Market Average Movement	6.4%
10% most volatile stocks in US Market	18.7%
10% least volatile stocks in US Market	3.2%

Stable Share Price: IBB has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: IBB's weekly volatility (3%) has been stable over the past year.

About the Company

Founded	Employees	CEO	Website
2001	n/a	n/a	www.ishares.com/us/products/239699/ishares-nasdaq-biotechnology-etf

iShares Trust - iShares Biotechnology ETF is an exchange traded fund launched by BlackRock, Inc. It is managed by BlackRock Fund Advisors. It invests in public equity markets of the United States. It invests in stocks of companies operating across biotechnology sectors.

iShares Trust - iShares Biotechnology ETF Fundamentals Summary

How do iShares Trust - iShares Biotechnology ETF's earnings and revenue compare to its market cap?
IBB fundamental statistics
Market cap	US$6.55b
Earnings (TTM)	US$359.15m
Revenue (TTM)	US$54.08m

18.2x

P/E Ratio

121.1x

P/S Ratio

Is IBB overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IBB income statement (TTM)
Revenue	US$54.08m
Cost of Revenue	US$0
Gross Profit	US$54.08m
Other Expenses	-US$305.06m
Earnings	US$359.15m

Last Reported Earnings

Sep 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)	7.60
Gross Margin	100.00%
Net Profit Margin	664.08%
Debt/Equity Ratio	10.8%

How did IBB perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

5%

Payout Ratio

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/02 02:45
End of Day Share Price	2025/01/31 00:00
Earnings	2023/09/30
Annual Earnings	2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

iShares Trust - iShares Biotechnology ETF is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution